Double Helix Appoints Ann Stuchiner Vice President of US Consulting Division

SCARSDALE, N.Y., March 30 /PRNewswire/ -- Double Helix Consulting US, a
division of London-based Double Helix Development group, today announced the
appointment of Ann Stuchiner to the position of Vice President. Stuchiner
joins a multidisciplinary team of highly experienced strategic pricing,
reimbursement and market access consultants with extensive experience across
the healthcare industry, which provide product commercialization services to
firms in the pharmaceutical, biotechnology and medical device industries. DHC
US provides services spanning the product lifecycle, including the following:

-- Product value message development and testing
-- Commercial assessment
-- Development program and clinical trial planning
-- Managed markets strategy
-- Pharmacoeconomic evaluation and health technology assessment
-- Payer and provider insight evaluation and influence planning
-- Pricing and reimbursement strategy, negotiation simulation, and
training
-- Market access training

(Logo: http://www.newscom.com/cgi-bin/prnh/20090330/NY91277LOGO )

Drew Baker, President of Double Helix Consulting US, commented, "Ann
complements our international market access, pricing and reimbursement
capabilities through her vast experience in planning and implementing product
development and launch strategies for the US market. Ann Stuchiner has led
product planning initiatives in myriad therapeutic areas and has particular
expertise in oncology, neurosciences, infectious disease, cardiometabolics,
gastroenterology and pain. Her intimate knowledge of managed care market
structure, formulary management, contracting strategies, and marketing
communications strengthens Double Helix's ability to meet our clients'
commercial objectives in the increasingly cost-conscious and value-driven US
market."

Chief Executive Officer of Double Helix Development Group, Dr. Wayne Phillips,
added, "Double Helix Consulting offers a premier set of services to assist our
clients in optimizing product commercialization by enhancing market access
through a truly global team of professionals with deep experience from both
the client and consulting sides. As an example, our growing emerging markets
practice provides clients with the intelligence to implement successful
strategies in the world's largest and most rapidly developing economies.
Ann's experience in product planning and launch strategy bolsters our
expanding capabilities."

Stuchiner founded and led the Managed Markets Group at FCB HealthCare. Prior
to FCB, her consulting career focused on development and implementation of
managed market access strategy to support commercial development and product
launches on behalf of major biopharmaceutical and device firms. She was also
Director of MC(2), the managed care division of Lowe McAdams. Prior to her
work in medical product commercialization strategy, Ann was a healthcare
benefit design consultant for major employers and managed care organizations.
She has served as an advisor to both the US Senate Subcommittee on Labor and
Healthcare Issues and the New York State Department of Insurance. She is a
graduate of Sarah Lawrence College and received her Master of Public Health
degree from Columbia University.

SOURCE Double Helix Consulting US

Andrew M. Baker, President, Double Helix Consulting US, +1-914-220-8388,
Mobile, +1-917-301-9216, dbaker@dhelixc.com